Recently, the China National Medical Products Administration（NMPA) granted approval to a groundbreaking 9-valent HPV vaccine, Cecolin®9, jointly developed by Xiamen Innovax Biotech Co., Ltd and Xiamen University. This milestone makes China the second country in the world, after the United States, capable of independently manufacturing and supplying the 9-valent HPV vaccine.